Evaluation of Boostrix™10 Years After Previous Booster Vaccination

Clinical trial NCT01147900 · COMPLETED

Trial details

NCT number: NCT01147900
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Acellular Pertussis Tetanus Diphtheria

Start date: 2010-06-15
Primary completion: 2012-05-08
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.